InsiderTrades

Form 4 for RJF Raymond James Financial

Accepted 2022-12-01 00:00:00 ET · period of report 2022-11-29 · accession 0001225208-22-012047 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2022-12-01 2022-11-30 RJF Perry Jodi Pres, ICD for RJFS A - Grant $0.00 +594 11.8K +5% $0
D 2022-12-01 2022-11-29 RJF Perry Jodi Pres, ICD for RJFS M - OptEx $0.00 +1,500 11.5K +15% $0
D 2022-12-01 2022-11-29 RJF Perry Jodi Pres, ICD for RJFS F - Tax $115.37 -365 11.2K -3% -$42.1K
D 2022-12-01 2022-11-29 RJF Perry Jodi Pres, ICD for RJFS M - OptEx $0.00 -1,500 1,500 -50% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-11-30 A A 594 $0.00 11,756 D — — (F2) Vesting of Performance Restricted Stock Units (PRSUs) granted on 12/13/2019. The PRSU grant was adjusted to reflect the stock split that occurred on September 21, 2021.
2 Common Common Stock 2022-11-29 M A 1,500 $0.00 11,527 D — — (F1) Each Restricted Stock Unit (RSU) represents a contingent right to receive, upon vesting of the award: (i) one share of common stock, and (ii) accrued cash in lieu of dividends.
3 Common Common Stock 2022-11-29 F D 365 $115.37 11,162 D — —
4 Derivative Restricted Stock Units 2022-11-29 M D 1,500 $0.00 1,500 D — · — to 2023-11-29 1,500 Common Stock (F1) Each Restricted Stock Unit (RSU) represents a contingent right to receive, upon vesting of the award: (i) one share of common stock, and (ii) accrued cash in lieu of dividends. (F4) RSUs vested 60% on 11/29/2021, 20% on 11/29/2022, and will vest 20% on 11/29/2023.